Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Tom Wilkes who wrote (83)	11/2/1997 4:21:00 PM
From: TheSlowLane	Read Replies (1) \| Respond to of 296

I have seen a couple of drug announcements involving Novartis recently but before that there was some press surrounding the work they are doing with genetically-engineered food products. It was interesting in that these products have met with some resistance in Europe (people just don't like their food engineered) but that there is generally better acceptance in the U.S. for these products. I don't know how this piece of the business compares to the pharmaceuticals but I suspect it's not altogether insignificant. I can't address your questions/concerns about Chiron, I don't know anything about it. I got hooked up with NVTSY through N&B.